A Clinical Study Examining the Impact of Transcendental Meditation and Amala Powder on Stage 1 Hypertension Patients' Systolic and Diastolic Blood Pressure

Abstract

This randomized clinical trial explores the effects of Amala powder (Emblica officinalis) and Transcendental Meditation (TM) on systolic and diastolic blood pressure in patients with stage 1 hypertension. Hypertension, a key risk factor for cardiovascular diseases, affects a significant portion of the global population. Non-pharmacological treatments such as herbal supplements and meditation practices offer potential alternatives to traditional antihypertensive medications. The study enrolled 90 participants and was divided into three groups: Group 1 received Amala powder, Group 2 practiced TM, and Group 3 combined both interventions over 3 months. Blood pressure, lipid profiles, and other cardiovascular markers were monitored throughout. Results demonstrated significant reductions in both systolic and diastolic blood pressure in all groups, with the most substantial improvements seen in Group 3, which combined both therapies. Additionally, Group 3 showed the greatest improvements in lipid profiles, particularly in increasing HDL cholesterol levels. These findings suggest that combining Amala powder and TM may offer a practical, holistic approach to managing hypertension and improving cardiovascular health.